
Loading, please wait...

Loading, please wait...

Managing mineral metabolism remains a significant challenge in chronic kidney disease (CKD). Recent research has uncovered a pivotal role for the OGR1 receptor PTH secretion mechanism in responding to extracellular acidity. While clinicians have long observed that metabolic acidosis exacerbates secondary hyperparathyroidism, the precise molecular sensors remained elusive until now. By utilizing 5-aminolevulinic acid to isolate parathyroid glands, scientists have demonstrated that acidic environments directly stimulate the release of parathyroid hormone (PTH).
The ovarian cancer G protein-coupled receptor 1 (OGR1), also known as GPR68, acts as the primary proton sensor in the parathyroid gland. In wild-type models, decreasing the extracellular pH leads to a significant increase in PTH secretion. Conversely, parathyroid glands lacking the OGR1 receptor fail to mount this response. This indicates that OGR1 is indispensable for the pH-dependent regulation of PTH. Furthermore, the study suggests that no other proton-sensing receptors compensate for its absence, making it a highly specific target.
Additionally, the research highlights a synergistic interaction between calcium and pH signaling. Low extracellular calcium levels not only stimulate PTH directly but also promote local acidification. This local drop in pH further activates the OGR1 receptor PTH secretion pathway. This dual stimulation significantly enhances hormone release. Notably, this synergy is markedly diminished in OGR1-deficient glands, confirming the receptor's central role in integrating these signals.
These findings provide a mechanistic bridge between metabolic acidosis and the progression of secondary hyperparathyroidism. In patients with CKD, the inability to excrete acid leads to chronic systemic acidosis. Consequently, this persistent acidic state may continuously drive PTH secretion via OGR1, independent of calcium levels. Therefore, targeting OGR1 signaling could offer a novel therapeutic avenue to control hyperparathyroidism without the side effects associated with traditional treatments.
OGR1, or GPR68, is a G protein-coupled receptor that senses changes in extracellular proton concentration. It translates acidic pH into intracellular signals that regulate various physiological processes, including hormone secretion.
Acidosis directly stimulates the parathyroid glands to release more PTH. This occurs through the activation of the OGR1 receptor, which detects the increased concentration of protons in the extracellular fluid.
Patients with CKD often suffer from metabolic acidosis and secondary hyperparathyroidism. Understanding that OGR1 mediates the acid-induced rise in PTH helps explain why acidosis worsens bone and mineral disorders in these patients.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers identify OGR1 as the primary proton sensor mediating PTH secretion during acidosis, highlighting a novel target for chronic kidney disease thera...
5 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday